LOXL4 and hepatocellular carcinoma: An increase in LOXL4 was observed in recipient HCC cells following treatment with EXO/LOXL4 (Fig. 7h); however, there was no change in the mRNA levels of LOXL4 in these cells (Additional file 2: Figure S7b).